Skip to main content

Table 1 Key results from 2009 ACTwatch survey in Kinshasa

From: The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013

Dates of data collection

August–September 2009

Sample

N

Outlets screened

2368

Outlets interviewed

778

Among all screened outlets, percentage that had

% (95% CI)

Public sector availability of quality-assured ACT

48.5 (32.8, 64.6)

Private sector availability of quality-assured ACT

14.1 (10.6, 18.6)

Public sector availability of non quality-assured ACT

20.0 (11.4, 32.8)

Private sector availability of non quality-assured ACT

60.7 (55.2, 66.0)

Public sector availability of oral artemisinin monotherapy

26.0 (15.4, 40.3)

Private sector availability of oral artemisinin monotherapy

70.4 (65.4, 75.0)

Anti-malarial market share

%

Market share of oral artemisinin monotherapy

10.8